Kein Folientitel

1
www.pathogenomics-era.net
2

• What is an ERA-NET?
• Structure of the ERA-NET PathoGenoMics / Boards,
  Work programme and activities
• Transnational Research Activities
• The todays subject Strategic Research Agenda

3
ERA-NET Schema
ERA-NET new instrument within the FP 6
Objective Strengthening the European Research
Area (ERA)
enhance the cooperation and coordination of
national research activities - through
networking of national/regional programmes
including their mutual opening and the
Objective
development and implementation of joint research
activities
4
ERA-NET Scheme
Eligible PartnersPartners are programme
owners/managers acting on behalf of
national/regional public authorities such as
ERA-NET does not include direct research funding,
but all measures for intergovernmental
coordination of existing or new funding
programmes.
ministries, funding agencies, research councils
5

• What is an ERA-NET?
• Structure of the ERA-NET PathoGenoMics / Boards,
  Work programme and activities
• Transnational Research Activities
• The todays subject Strategic Research Agenda

6
Boards
Network Steering Committee NSC Funding
Organisations
Affiliated Partners Funding Organisations
External Advisory Board EAB Scientists
7
ERA-NET Schema
Activities
1. Systematic exchange of information best
practices
2. Common strategies
3. Development of common activities
4. Implementation of transnational research
activities
8
9/2005
4/2005
01/2006
WP 7 Development of a legal, contractual and
financial Framework and application/ evaluation
system
Agreement Framework and application/ evaluation
system
WP 8first Joint call
WP 1 2 information exchange about the national
programmes Commitment of the partners regarding
joint call
Agreement on European Research Agenda
WP 3 development of a European Research Agenda
WP 6 Partne-ring Event
Development of transnationalresearch consortia
WP 4 SMEs/industry working group, PIPs network
(PathoGenoMics innovation partners)
WP 6 Working group on training issues
WP 9 Science and Society IT-based communication
platforms for the public, Printed information
material, On-spot-presentations
9
12/2005
10/2004 Start
9/2005
4/2005
2007
2004
WP 7 development of the admin. framework
Application/ evaluation system
Agreement about admin. framework and appl./
eval. system
WP 1 2 information exchange about the national
programmes Commitment of the partners regarding
joint call
Work programmemilestonesdeliverables
Agreement about SRA
WP 3 development of a strategic Research Agenda
Partne-ring Event
WP 6 development of transnationalresearch
concortia
WP 4 SMEs/industry working group
WP 6 working group training issues
WP 9 Wissenschaft und Gesellschaft
Kommunikationsplattform
10

• Public accessible database, contains information
  about and allows searches for
• Research groups in the Pathogenomics field
• topics of current research projects
• Studied microorganisms
• Will probably be available in 4 weeks
• -gt please supplement these information with e.g.
  
• summaries of your own research topics, link to
  your web page

WP 9 Science and Society IT-based communication
platforms for the public, Printed information
material, On-spot-presentations
11

• What is an ERA-NET?
• Structure of the ERA-NET PathoGenoMics / Boards,
  Work programme and activities
• Transnational Research Activities
• The todays subject Strategic Research Agenda

12
Transnational Research Activities -
nationality principle (each country shall fund
ist own research entities) - countries
participating in the first joint call
maybe also participating - research groups
from other countries may also participate,
provided they have their own funding
Austria, Finland, Germany, Slovenia, Spain
France, Israel, Latvia, Portugal, Sweden
13
Transnational Research Activities - who may
submit proposals? Research groups, organised in
transnational consortia, will submit a consorted
proposal
- which topics will be funded? Topics covering
Genome Research on pathogenic Microorganisms
(details will be given in the call for proposals,
approx. Jan. 2006)
- will there be further regulations? yes, e.g.
transnational research consortia, consorted
proposals variable geometrie details are still
to be defined further regulations will be
published in the call text
14

• What is an ERA-NET?
• Structure of the ERA-NET PathoGenoMics / Boards,
  Work programme and activities
• Transnational Research Activities
• The todays subject Strategic Research Agenda
  for PathoGenoMics

15
Time schedule Strategic Research Agenda (SRA)
Helsinki 26.-27.09.05
Paris 23.-25.05.05
06/2005
07/2005
2005
Expert Meeting indepth discussion about SRA,
develop-ment of a first draft SRA by Rapporteurs
Publication of the SRA draft in FEMS letters
(and other journals)
Agreement on SRA
Scientific feedback
16
Thank you for your kind attention !
17
Workpackage 3 Strategic Research Agenda (SRA)

• Why a Strategic Research Agenda for
  PathoGenoMics?
• To define the most important topics for future
  PathoGenoMics research
• To outline the importance of this topic
• gt basis for discussions with
• national funding authorities (e.g. development
  of new programmes)
• European Commission
• other stakeholders

18
Pathogenomics A Proposed European Research
Agenda
A The microbes
B Host-microbe interactions
C Development and improvement of tools
D. Integration at a European Level
19
Workpackage 3 Strategic Research Agenda (SRA)
T 3.2 Indepth discussion with high-level experts,
23rd 25th May 2005, Paris Based on first ideas
to structure a European Research Agendadeveloped
on a 1st preparatory meeting (June 2003,
Würzburg) 3.2(a) Civil Aspects of
pathogenomics3.2(b) Impact of pathogenomics on
biosecurity and safety research
20
Workpackage 3 Strategic Research Agenda (SRA)

• T 3.3 Feedback from the scientific community
• Rapporteurs will summarise the indepths expert
  discussion and continue drafting the agenda (up
  to 20 pages)
• Draft Research Agenda will be published in FEMS
  Letters in order to create a scientific feedback
  loop (deadline approx. 2 months)
• final version of the European Pathogenomics
  Research Agendain September 2005

21
(No Transcript)
22
(No Transcript)
23
(No Transcript)